New probe aims to crack the code of IVF failure

NCT ID NCT06259084

Completed Knowledge-focused Sponsor: Manina Medtech Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a device called Seedchrony that measures a natural chemical in the uterus to see if it can predict whether an embryo transfer will lead to pregnancy. The study involved 92 women undergoing their first IVF cycle. The goal is to find a way to improve the low success rate of IVF, which is currently below 40%.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Seedchrony probe (device measuring intrauterine biomarker)
What this could lead to: If successful, this could lead to a simple test that helps doctors choose the best time for embryo transfer, potentially improving IVF success rates.
What could go wrong: This is a small pilot study (92 participants) that only measures a biomarker—it does not test whether using the device actually improves pregnancy rates. The results may not apply to all IVF patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFERTILITY

Contacts and locations

Locations

Vall d'Hebron Hospital

Barcelona, Other (Non US), 08035, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.